top of page
Blog
At Drug Science we like to cover different topics relating to drugs. These topics cover the many different ways that psychoactive substances have an impact on our culture and society.
Royal College of Psychiatrists Calls for Improved Trauma Care: Could Psychedelic-Assisted Therapy Help?
The Royal College of Psychiatrists issued a position statement at the end of August highlighting the need for improved care and systems to address the impact of non-recent child sexual abuse (CSA) on the mental health of adults. Like other forms of trauma, the report noted how CSA is alarmingly prevalent and has enduring consequences for health and wellbeing but lacks adequate, effective treatment. The immediate past President of the Royal College of Psychiatrists Dr Lade Sm
Michael Lynskey
Sep 243 min read
MDMA and Psilocybin Education, Refreshed
We're proud to release updated MDMA and psilocybin educational modules, developed with Norrsken Mind and Mind Medicine Australia, bringing pharmacology, history, and law fully up to date.
Drug Science
Jul 282 min read
Australian government funds psychedelic assisted therapy for veterans in a global leading decision
The Department of Veterans Affairs in Australia have recently decided to fund MDMA-assisted psychotherapy for PTSD and psilocybin-assisted psychotherapy for treatment resistant depression among military veterans.
Isabel Faulkner
Nov 24, 20252 min read
UK Government supports ACMD plan to enable research with schedule 1 medicines such as psilocybin and MDMA
Despite the resurgence of research into the clinical efficacy and mechanism of action of psychedelic drugs such as such as psilocybin, LSD, DMT, and MDMA they are currently in Schedule 1 of the Misuse of Drugs regulations 2001.
Jody Chu, James Bunn and Prof Jo Neill
Jul 30, 20255 min read
MDMA-assisted therapy: challenges, clinical trials, and the future of MDMA in treating behavioral disorders
Despite recent setbacks for the clinical application of MDMA, the chapter argues that it holds potential for transforming psychiatry and
David Nutt
Jan 30, 20251 min read
The Australia story: Current status and future challenges for the clinical applications of psychedelics
The past decade has seen a huge increase in clinical research with psychedelic drugs and 3,4-methylenedioxymethamphetamine (MDMA)
David J Nutt, Peter Hunt, Anne Katrin Schlag and Paul Fitzgerald
Dec 18, 20241 min read
Allaying the fears: Midomafetamine with therapy is a medicine
MDMA (now called midomafetamine by the FDA) is a substituted amphetamine first synthesised in 1912 by Merck that has been developed over the
David J Nutt, Tadeusz Hawrot, Peter Hunt and Anne Katrin Schlag
Sep 24, 20243 min read
Drug Science and University College London Collaboration: Advancing MDMA-Assisted Therapy
Drug Science and UCL are pleased to announce their collaboration aimed at advancing our understanding of MDMA-assisted psychotherapy.
James Bunn
Sep 3, 20243 min read
3,4-Methylenedioxymethamphetamine (MDMA) consumption in Aotearoa New Zealand: A quantitative survey exploration
The prevalence of 3,4-methylenedioxymethamphetamine (MDMA) consumption is relatively high in Aotearoa New Zealand, but MDMA use has not been
Jai Whelan, Geoff Noller, and Ryan D Ward
Aug 18, 20242 min read
Allaying the fears: MDMA with therapy is a medicine
MDMA has been developed over the past 30 years by the Multidisciplinary Association for Psychedelic Studies as a novel treatment for PTSD.
Prof David Nutt, Tadeusz Hawrot, Peter Hunt, and Dr Anne Katrin Schlag
Aug 6, 202425 min read
“SIZE MATTERS”: High strength ecstasy pills are back, so harm reduction communications need to adapt
Average pill strength has increased in 2024, back to pre-pandemic levels
Prof Fiona Measham and Adam Waugh
Jun 25, 20246 min read
Doubt it not, MDMA is a medicine
The AdCom was asked to make a binary yes-no vote on both the efficacy and benefit-risk of MDMA, with scores of 9-2 and 10-1 against for each
Prof David Nutt and Prof Jo Neill
Jun 21, 20246 min read
Report of the Dutch State Committee on MDMA: A summary of findings and recommendations
On June 6, 2024, the Dutch State Committee MDMA presented its report entitled “MDMA: Beyond ecstasy” to the Dutch Minister of Medical Care.
Wim van den Brink
Jun 19, 20244 min read
How can we prepare psychiatry for a psychedelic future?
The Therapeutic Goods Administration (TGA) in Australia recently made a groundbreaking decision to reschedule two drugs as treatments for ce
Drug Science
May 23, 20243 min read
From prohibited to prescribed: The rescheduling of MDMA and psilocybin in Australia
On February 3, 2023, the Therapeutic Goods Administration (TGA), Australian Government Department of Health and Aged Care, announced that on
Octavian Dixon Ritchie, Cameron Donley and more
Sep 7, 20231 min read
MDMA-assisted psychotherapy with adolescents suffering from PTSD: Do or don’t? a qualitative study with youth, parents, and clinicians
PTSD in adolescence causes much suffering and has substantial health-care costs. The purpose of this study is to investigate the perspective
Anoek Van Vugt, Josjan Zijlmans and more
Sep 2, 20231 min read
Over One Hundred Years of MDMA Research
Written by Libby Furminger History 3,4-Methylenedioxymethamphetamine (MDMA), also known as Mandy, Molly, Ecstasy or ‘E’, is a class A...
Libby Furminger
Jun 29, 202210 min read
3. MDMA History & Law
Download Module Here #educationalresources #HistoryandLaw
Drug Science
Apr 11, 20221 min read
4. MDMA Pharmacology
Download Module Here #educationalresources #Pharmacology
Drug Science
Apr 11, 20221 min read
Effects of Mixing and Dosing MDMA, LSD, and 2C-B with Dr Friederike Meckel Fischer
Dosing in psychoactive drugs Dosing represents one of the three critical elements that determine the quality of a drug experience,...
Drug Science
Oct 23, 20214 min read
Ask the experts: Psilocybin and MDMA Research
In this webinar, two of the world’s leading psychedelic research experts; Dr Ben Sessa and Dr Meg Spriggs, answer questions on the...
Drug Science
Sep 14, 20212 min read
bottom of page